Further studies showed that depletion of regulatory T cells in pancreatic cancer led to differentiation of inflammatory fibroblast subpopulations, which in turn drove infiltration of bone marrow cells via CCR1, thus revealing a potential new therapeutic approach to alleviate immunosuppression in pancreatic cancer (Zhang et al., 2020). This evidence concerns the gene CCR1 and familial pancreatic carcinoma.